Shorts

0:50

Patient-Centered Care Should Drive Sarcoma Research

3 hours ago

Emily J. Papai, MD

Suzann Duan, PhD, discussed the potential link between immunosenescence and the emergence of immunologically “cold” tumor microenvironments in GEP-NETS.

1:21

Is There a Link Between Immunosenescence and “Immune Cold” TMEs in NETs?

5 hours ago

Suzann Duan, PhD

In a discussion with CancerNetwork®, Ram Prakash Thirugnanasambandam, MBBS, spoke about a manuscript he published in the November/December 2025 issue of the journal ONCOLOGY® focusing on the role that artificial intelligence (AI) can play in palliative care and hematologic malignancies.

0:55

Implementing AI as a Supportive Tool in Palliative Oncological Care

8 hours ago

Ram Prakash Thirugnanasambandam, MBBS

Mauro Cives, MD, discussed a surprising finding in his research, which won an investigator award from the Neuroendocrine Tumor Research Foundation.

1:07

Some TILs May Exploit Antitumor Activity in Pancreatic NETs

a day ago

Mauro Cives, MD

$Shambavi Richard, MD, spoke with CancerNetwork® about findings from the phase 1b portion of the DURGA-1 trial (NCT05850234) assessing AZD0120, a novel BCMA/CD19 dual-targeting cellular therapy, among those with relapsed/refractory multiple myeloma.$

0:39

AZD0120 Shows “Excellent” Response Rates in R/R Multiple Myeloma

a day ago

Shambavi Richard, MD

Dominique Rash, MD, highlighted what patient factors and characteristics guide how radiation oncologists coordinate utilizing radiation with systemic therapy for patients with inoperable endometrial cancer.

0:56

Sequencing Radiation With Systemic Therapy in Inoperable Endometrial Cancer

2 days ago

Dominique Rash, MD

0:41

Why Survivorship is the Next Phase of Cancer Research

2 days ago

Fumiko Chino, MD

$In a conversation with CancerNetwork® at the 2026 American College of Radiation Oncology (ACRO) Summit, Pranshu Mohindra, MD, discussed the evolution of hypofractionated radiotherapy in the lung cancer field, which may help expedite the treatment process for patients$

0:46

How Has Hypofractionation Made Lung Cancer Radiotherapy More Convenient?

4 days ago

Pranshu Mohindra, MD

Monzr M. Al Malki, MD, described TRX103, an off-the-shelf allogenic T-cell therapy, contextualized by a presentation he gave at the 2026 Tandem Meetings.

0:42

TRX103: The Future of Allogeneic T-Cell Therapy?

5 days ago

Monzr Al Malki, MD

1:27

When to Use Checkpoint Inhibitors in Sarcoma Therapy

5 days ago

Seth M. Pollack, MD

Vanessa Almendro Navarro, PhD, MBA, encourages her colleagues to envision an ideal state of City of Hope as an organization as opposed to succumbing to the fear of change.

0:57

Overcoming Fear to Change in the Commercialization Aspect of Oncology

6 days ago

Vanessa Almendro Navarro, PhD, MBA

Irtiza N. Sheikh, DO, touched upon key questions that emerged following the publication of research evaluating liso-cel between patients younger than 50 and those 50 years and older in both the real-world and clinical trial settings.

1:13

Highlighting Key Questions in Liso-Cel Treatment Across Lymphoma Settings

7 days ago

Irtiza N. Sheikh, DO

Vanessa Almendro Navarro, PhD, MBA, highlighted the importance of collaboration between oncology departments to facilitate drug development for use in oncology care.

1:14

Collaboration Across Departments is Key in Oncology Development

8 days ago

Vanessa Almendro Navarro, PhD, MBA

Looking back at the long-term effects of the COVID-19 pandemic on oncology care, Daniel C. McFarland, DO, spoke with CancerNetwork® about how this health crisis impacted his interactions with patients from a psycho-oncology perspective.

0:36

COVID-19 Was ‘Added Layer of Trauma’ in Psycho-Oncology Care

8 days ago

Daniel C. McFarland, DO

0:49

Personalizing Diet Based on Patient Risk and Metabolism

8 days ago

Ifeoma Dikeocha, PhD

Irtiza N. Sheikh, DO, discussed key efficacy findings from a comparative analysis of liso-cel among patients younger than 50 with large B-cell lymphoma (LBCL) in the real-world and clinical trial settings.

0:50

Data Show Similar Liso-Cel Efficacy in Young LBCL Groups Across Settings

9 days ago

Irtiza N. Sheikh, DO

0:38

The Missing Link in Cancer Research: Diversity

9 days ago

Kathie-Ann Joseph, MD, MPH, FACS

A study published in Lancet Oncology demonstrated that radiation is a feasible method to treat celiac plexus-associated pain in patients with gastrointestinal cancers.

0:57

Using Radiation to Treat Celiac Plexus-Associated Pain in GI Cancers

10 days ago

Michael Buckstein, MD, PhD

0:53

Revolutionizing Breast Cancer: From 7 Weeks to 1 Week of Radiation

10 days ago

Parul Barry

0:38

Beyond Mastectomy: The Power of Oncoplastic Surgery

10 days ago

Kathie-Ann Joseph, MD, MPH, FACS

1:52

ACRO Day 2 Quick Take With CancerNetwork

12 days ago

Ariana Pelosci(+1 more)

0:43

The Complex Decisions in Treating DCIS Breast Cancer

12 days ago

Jean L. Wright, MD, FASTRO

Yun Rose Li, MD, PhD, spoke about the inspiration behind her team’s assessment of cardiovascular risks with hormone therapy for prostate cancer in the phase 2 IMPACT-ADT trial.

1:27

STEMI Event Inspires Prostate Cancer Trial Assessing Cardiovascular Risk

13 days ago

Yun Rose Li, MD, PhD

As part of a conversation with a CancerNetwork®, Manoj Bhasin, PhD, MS, discussed the next steps for refining the development of next-generation therapies for patients with newly diagnosed multiple myeloma (NDMM) following novel translational findings that he and colleagues published in Nature Cancer.

0:48

Translating Cytogenetic Data Into Next-Generation Therapies in NDMM

13 days ago

Manoj Bhasin, PhD, MS

0:48

ACRO Day 1 Quick Take With CancerNetwork

13 days ago

Ariana Pelosci(+1 more)

Yun Rose Li, MD, PhD, discussed a balancing act when considering treatment with hormone therapy for patients with late-stage prostate cancer, particularly those who are at a higher risk of cardiovascular events.

1:06

Balancing Cardiovascular and Prostate Cancer Risks in Oncology Treatment

15 days ago

Yun Rose Li, MD, PhD

In honor of World Cancer Day, Paolo Tarantino, MD, spoke with CancerNetwork® about the current state of the oncology field and how it may continue to evolve.

0:51

Social Media and AI Are Expanding With the Data in Oncology Research

15 days ago

Paolo Tarantino, MD, PhD

1:01

How Can Diet Improve Chemotherapy Results?

15 days ago

Ifeoma Dikeocha, PhD

Arturo Loaiza-Bonilla, MD, MSEd, FACP, touched upon studies such as the PANORAMA trial, which assessed early detection of pancreatic cancers through AI–assisted CT scans.

0:47

Employing Artificial Intelligence to Detect Early-Stage Pancreatic Cancer

16 days ago

Arturo Loaiza-Bonilla, MD, MSEd, FACP

Shorts

Trending on CancerNetwork

ASCO Issues Updated Guideline for Stage IV NSCLC Therapy

FDA Accepts NDA for Iberdomide Combination in R/R Multiple Myeloma

First-in-World Trial Explores Subcutaneous Blinatumomab in Rare Leukemia

Onvansertib Triplet Improves Efficacy in First-Line RAS-Mutated mCRC

Gastrectomy Increases Risk of Gallstone Disease in Gastric Cancers